From: Integrated proteogenomic characterization of urothelial carcinoma of the bladder
Characteristic | TCGA cohort (N = 412) | Beijing cohort (N = 120) | Fudan cohort (N = 116) | Chi-square p value |
---|---|---|---|---|
Age—no. (%) | ||||
  ≥ 70 yr | 195 (47) | 49 (41) | 45 (39) | 0.173 |
  < 70 yr | 217 (53) | 71 (59) | 71 (61) |  |
Gender—no. (%) | ||||
 Male | 108 (26) | 31 (26) | 28 (24) | 0.903 |
 Female | 304 (74) | 89 (74) | 88 (76) |  |
Smoking—no. (%) | ||||
 Yes | 288 (70) | 30 (25) | 18 (15) |  < 2.2E−16 |
 No | 124 (30) | 90 (75) | 98 (85) |  |
Geographical features—no. (%) | ||||
 Asian | 31 (7) | 120 (100) | 116 (100) |  < 2.2E−16 |
 Others | 381 (93) | 0 | 0 |  |
Histologic grade—no. (%) | ||||
 High | 388 (94) | 109 (91) | 110 (95) | 0.332 |
 Low | 21 (5) | 11 (9) | 6 (5) |  |
 ND | 3 (1) | 0 | 0 |  |
T stage—no. (%) | ||||
 Ta | 0 | 7 (6) | 11 (9) |  < 2.2E−16 |
 Tis | 0 | 4 (3) | 0 |  |
 T1 | 1 (< 1) | 36 (30) | 34 (29) |  |
 T2 | 123 (30) | 34 (28) | 46 (40) |  |
 T3 | 196 (48) | 36 (30) | 22 (19) |  |
 T4 | 59 (14) | 3 (3) | 3 (3) |  |
 TX | 1 (< 1) | 0 | 0 |  |
 ND | 32 (8) | 0 | 0 |  |
History of treatment—no. (%) | ||||
 Yes | 10 (2) | 0 | 0 | 0.055 |
 No | 402 (98) | 120 (100) | 116 (100) |  |